Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Vaniqa

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Vaniqa est un médicament délivré uniquement sur prescription médicale et commercialisé en tube de 30 g. Vaniqa s’utilise à raison… Expand
Review
2005
Review
2005
  • B. Thiebot
  • Annales de dermatologie et de venereologie
  • 2005
  • Corpus ID: 3674852
Review
2005
Review
2005
  • S. Dahan
  • Annales de dermatologie et de venereologie
  • 2005
  • Corpus ID: 27909966
Review
2004
Review
2004
Hirsutism, the appearance of facial hair on women in a male pattern distribution, is a problem with potential medical, social… Expand
2001
2001
Eflornithine HCl 13.9% cream is the first topical prescription treatment to be approved by the US FDA for the reduction of… Expand
2001
2001
Summary Eflornithine HCl 13.9% cream (Vaniqa™) is a novel treatment for the management of unwanted facial hair in women. This… Expand